Bignon, Alexandre <br/><br/>
CCR1 inhibition ameliorates the progression of lupus nephritis in NZB/W mice.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  Feb 2014 
 - 886-96 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1550-6606 
<br/><br/><label>Standard No.: </label>10.4049/jimmunol.1300123  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Animals<br/>B-Lymphocytes--immunology<br/>Chemokine CCL3--biosynthesis<br/>Chemokine CCL5--biosynthesis<br/>Chemotaxis, Leukocyte<br/>Disease Progression<br/>Drug Evaluation, Preclinical<br/>Humans<br/>Kidney--immunology<br/>Ligands<br/>Lupus Nephritis--immunology<br/>Mice<br/>Mice, Inbred NZB<br/>Myeloid Cells--drug effects<br/>Neutrophil Infiltration--drug effects<br/>RNA, Messenger--biosynthesis<br/>Random Allocation<br/>Receptors, CCR1--antagonists & inhibitors<br/>Spleen--immunology<br/>Splenomegaly--etiology<br/>T-Lymphocyte Subsets--drug effects